Phenoxodiol phase Ib/II study in patients with recurrent ovarian cancer that is resistant to ≥ second line chemotherapy.

被引：0
|
作者：
Rutherford, T [1 ]
O'Malley, D [1 ]
Makkenchery, A [1 ]
Baker, L [1 ]
Azodi, M [1 ]
Schwartz, P [1 ]
Mor, G [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
来源：
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION | 2004年 / 11卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
254
引用
收藏
页码：156A / 157A
页数：2
相关论文
共 50 条
  • [1] Second Line Chemotherapy with Docetaxel in Patients with Recurrent Malignant Glioma: A Phase II Study
    M. Sanson
    M. Napolitano
    R. Yaya
    F. Keime-Guibert
    Ph Broët
    K. Hoang-Xuan
    J.Y. Delattre
    Journal of Neuro-Oncology, 2000, 50 : 245 - 249
  • [2] Second line chemotherapy with docetaxel in patients with recurrent malignant glioma:: a phase II study
    Sanson, M
    Napolitano, M
    Yaya, R
    Keime-Guibert, F
    Broët, P
    Hoang-Xuan, K
    Delattre, JY
    JOURNAL OF NEURO-ONCOLOGY, 2000, 50 (03) : 245 - 249
  • [3] Recurrent/progressive oligodendroglial tumors:: A phase II study with temozolomide as first line chemotherapy.
    Soffietti, R.
    Rudà, R.
    Guarneri, D.
    Laguzzi, E.
    Trevisan, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 73S - 73S
  • [4] Management of metastatic colorectal cancer (CRC) in elderly patients: Results of a phase II study with first or second line raltitrexed chemotherapy.
    Oliva, C
    Cutin, SC
    Boglione, A
    Dal Canton, O
    Bergnola, P
    Brizzi, MP
    Pochettino, P
    Comandone, A
    ANNALS OF ONCOLOGY, 2000, 11 : 71 - 71
  • [5] Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer
    Jivesh J. Sharma
    Betty Razvillas
    C.D. Stephens
    Susan G. Hilsenbeck
    Ashu Sharma
    Mace L. Rothenberg
    Investigational New Drugs, 1997, 15 : 361 - 364
  • [6] Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer
    Sharma, JJ
    Razvillas, B
    Stephens, CD
    Hilsenbeck, SG
    Sharma, A
    Rothenberg, ML
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (04) : 361 - 364
  • [7] A phase Ib/II study to evaluate surufatinib combined with camrelizumab and chemotherapy in the second-line treatment of advanced colorectal cancer: Phase Ib results
    Li, Sheng
    Zhu, Liangjun
    Li, Xiaoyou
    Huang, Jiayuan
    Bao, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer
    Bruchim, Ilan
    Jarchowsky-Dolberg, Osnat
    Fishman, Ami
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 166 (01) : 94 - 98
  • [9] Phase II study of fenretinide in patients with small cell lung cancer (SCLC) with progression after first- or second-line chemotherapy.
    Schneider, BJ
    Worden, F
    Gadgeel, S
    Hodges, C
    Parchment, R
    Zwiebel, J
    Kraut, M
    Kalemkerian, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 690S - 690S
  • [10] Phase II Study of Pemetrexed as Second or Third Line Combined Chemotherapy in Patients with Colorectal Cancer
    Wu, Xue-Yan
    Huang, Xin-En
    You, Shan-Xi
    Lu, Yan-Yan
    Cao, Jie
    Liu, Jin
    Xiang, Jin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (03) : 2019 - 2022
12345